Yonalink and PSP Announce Collaboration to Streamline Electronic Health Record data into EDC Systems for Clinical Trials in Japan

TOKYO, Jan. 6, 2026 /PRNewswire/ -- Yonalink and PSP today announced a strategic collaboration aimed at simplifying the integration of medical information stored in Electronic Health Records (EHRs) into Electronic Data Capture (EDC) systems used in clinical trials. This initiative is designed to enhance operational efficiency and expand opportunities for global clinical trials conducted in Japan.

PSP will leverage its advanced medical information management technologies developed through its cloud-based PACS (Picture Archiving and Communication System), while Yonalink will apply its innovative automated integration and data mapping capabilities that enable seamless connectivity with multiple EDC platforms. By combining their respective strengths, the two companies aim to significantly reduce the burden of manual data entry, improve data accuracy, and accelerate the overall clinical trial process.

Through this collaboration, Yonalink will extend its network of connected healthcare institutions to Japan—its first expansion into Asia. This will further strengthen Yonalink's position as a global EHR-to-EDC leader supporting international collaborative clinical trials across the United States, Europe, and Asia, and will contribute to the company's accelerated global growth.

Yoshihisa Yoda, CEO of PSP, commented:
"We are delighted to collaborate with Yonalink, a company pioneering the digitalization of data collection in clinical research. PSP has long been committed to ensuring the secure and effective use of medical information through our cloud-based solutions and patient-centered services. By leveraging our technologies together with Yonalink, we aim to drive innovative approaches to utilizing medical data that will streamline various processes in clinical trials."

Iddo Peleg, CEO of Yonalink, added:
"At Yonalink, our goal is to remove barriers that slow down clinical research by making the flow of data from hospitals to EDC systems simple, automated and reliable. Partnering with PSP allows us to bring this capability to Japan, a country with exceptional medical infrastructure and growing global trial activity. Together, we are creating a more efficient and scalable model for clinical data collection that will support Japan's role in global clinical development."

This partnership reflects a shared commitment to supporting the growth of international collaborative clinical research in Japan and contributing to improved patient outcomes through more efficient data management in clinical trials.

Corporate Profiles
Yonalink
Yonalink, based in Tel Aviv, Israel, was established in 2019. The company's mission is to make clinical trials accessible to any patient anywhere, while bringing new levels of speed, quality and efficiency to clinical trial operations across the globe, simplifying the complexity of clinical data collection and validation, and enabling true scalability.

PSP Corporation
PSP Corporation, based in Tokyo, Japan, was established in August 1989. The company has a strong track record in the PACS (Picture Archiving and Communication System) market in Japan, with installations at over 2,500 medical facilities and more than 1,600 facilities using its cloud-based PACS solutions.

PSP's cloud PACS platform securely manages data for more than 68 million patients and over 450 million imaging examinations. Leveraging its medical cloud infrastructure, the company is also advancing the provision of Personal Health Record (PHR) services and AI-powered diagnostic imaging solutions.

CONTACT: [email protected]

SOURCE Yonalink